Royal Medical Centers Review

What Royal Medical Centers charges

• MOTS-C$300/mo — the product page prints both "$300 for 1 Month" and "Pricing: $300/month"; two months is $550Injection
• Sermorelin$175/mo — per month; the same page prices two months at $325Sermorelin Acetate, injection
• Tesamorelin$200/mo — for one month, against a 6ml vial the page describes as a one-month supply; two months is $3502mg/ml, 6ml vial for one month

Royal Medical Centers also sells 7 compounds this site boards without publishing a price for them: GHK-Cu, BPC-157 (board ranks no provider), TB-500 (board ranks no provider), Ipamorelin (board ranks no provider), CJC-1295 (board ranks no provider), Semaglutide and Tirzepatide.

What Royal Medical Centers publishes

• Not disclosedNames the pharmacy that fills it
• PublishedPublishes a price before intake
• Not disclosedShips to all 50 states
• Not disclosedIncludes lab work in the price
• Not disclosedNames the clinician who prescribes
• Not disclosedStates whether a membership fee applies

Cancellation, refunds and shipping

What Royal Medical Centers states on its own site about leaving, getting money back, and what delivery costs. Read on September 2026.

• Not statedCancellation: The whole page was rendered and read rather than inferred. The site links exactly three documents: an FDA Disclaimer, a Compounding Disclaimer and a Privacy Policy. No terms of service, refund, shipping or cancellation page exists, and no cancellation route, deadline or notice period appears in the rendered homepage text.
• Not statedRefund: Again on the rendered page: no occurrence of a refund term anywhere on the homepage, and none of the three linked documents (FDA Disclaimer, Compounding Disclaimer, Privacy Policy) is a refund policy.
• Not statedShipping: Again on the rendered page: the homepage sells "Delivered To You" as a step in the treatment process and publishes no cost, window, carrier or condition for it.

Membership fees

Whether Royal Medical Centers charges to belong, on top of what it charges for the medication. Read on September 2026.

• Not statedRoyal Medical Centers publishes nothing about a membership on any page we checked.

Who prescribes

Whether Royal Medical Centers identifies the clinician or medical practice behind the prescription, or describes them only as a group. Read on September 2026.

• Not namedRoyal Medical Centers does not name a prescriber on any page we checked — its clinicians are described as a group rather than identified.

Eleven products, every one of them priced

Royal Medical Centers sells eleven peptide products, and each one has its own page with its own price on it.

Every page prints a one-month figure and a two-month figure beside it. The two-month figure is lower than twice the monthly one, so a longer commitment costs less per month.

Two of the eleven are compounds outside this comparison, and four are blends of two or three peptides.

The three you can price on their own

MOTS-C is priced for one month with a two-month figure beside it. The page prints the same monthly figure twice, once in prose and once in the pricing line.

Sermorelin acetate is priced the same way, per month with a two-month option.

Tesamorelin is the clearest of the three. Its page states a vial strength and volume and calls that a one-month supply, so you can check the month against a quantity instead of taking it on trust.

The blends cost the same to buy and are harder to compare

A copper-peptide, BPC-157 and TB-500 injection is priced for one month. So is a tesamorelin and ipamorelin injection, and a three-ingredient metabolic blend. A CJC and ipamorelin injection is listed as well.

Each of those figures buys two or three drugs at once. None of them is the price of a single peptide inside the vial, so you cannot line one up against a seller that prices one compound at a time.

Royal Medical Centers does dispense these compounds. What is missing is a price scoped to any one of them.

What it admits, and what it won't tell you

Its own disclaimer says the FDA does not verify the safety, effectiveness or quality of compounded drugs offered at the clinic. It adds that compounded drugs are not FDA-approved and do not undergo safety, effectiveness or manufacturing review.

It says medications are dispensed by licensed pharmacies, and that a provider may prescribe a drug prepared by a state-licensed sterile compounding pharmacy partner. The partner is never named, so there is no facility you can look up.

No state list is published, and no certificate of analysis is reachable. You find out whether it can serve you by asking.

Who Royal Medical Centers suits

Strengths and trade-offs

How we verified this

• All eleven peptide product pages were read in September 2026, and every price comes from the page itself.
• Each product page prints a one-month figure and a two-month figure, and the two-month figure is lower than twice the monthly one.
• Four of the eleven products are blends of two or three peptides, and two are compounds outside this comparison.
• The tesamorelin page states a vial strength and volume and describes that quantity as a one-month supply.
• The brand and the operating name were checked against the federal warning-letter database in September 2026.